CoChat

The prevalence of the metabolic syndrome in patients with schizoaffective disorder – bipolar subtype

Basu, Ranita, Brar, Jaspreet S, Roy Chengappa, KN, John, Vineeth, Parepally, Haranath, Gershon, Samuel, Schlicht, Patricia, Kupfer, David J · 2004 · Bipolar Disorders
Cited by 134

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Objectives: To evaluate the point prevalence of the metabolic syndrome in patients with schizoaffective disorder – bipolar type. Methods: Consenting patients who were participants in an ongoing clinical trial of adjunctive topiramate treatment for schizoaffective disorder, bipolar type were evaluated at baseline for the point prevalence of the metabolic syndrome. The criteria for the metabolic syndrome included: (a) waist circumference > 102 cm (40 inches) in males, or > 88 cm (35 inches) in females; (b) fasting serum triglyceride levels ≥ 150 mg/dL; (c) fasting high density lipoproteins (HDL) cholesterol <40 mg/dL in men or <50 mg/dL in women; (d) blood pressure ≥ 130/85 mmHg; and (e) fasting glucose ≥ 110 mg/dL. Subjects who had at least three of these five criteria were defined as meeting criteria for the metabolic syndrome. Results: Thirty‐six subjects (males = 15, females = 21) were evaluated, and three were excluded for missing data. Among those 33 subjects with complete data, 14 subjects (42.4%, males = 7, females = 7, African Americans = 6, Caucasians = 8) met criteria for the metabolic syndrome. Not unexpectedly, those with the metabolic syndrome were significantly more likely to be obese, and have significantly higher mean systolic and diastolic blood pressure, mean fasting triglyceride levels and larger mean waist circumferences, and significantly lower HDL cholesterol levels; and a trend toward higher fasting blood glucose levels. Furthermore, the fasting mean total cholesterol in those with the metabolic syndrome was 217 mg/dL (±46). Conclusions: This preliminary report suggests that the point prevalence of the metabolic syndrome in patients with schizoaffective disorder appears to be higher than that reported in the general population of the USA. Targeted weight reduction and life style change strategies (increased exercise, smoking cessation, stress reduction) may provide useful interventions to decrease the morbidity and mortality that accompanies the presence of the metabolic syndrome in patients with psychiatric illnesses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1399-5618.2004.00126.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 134

Metadata

Authors
Basu, R., Brar, J. S., Roy Chengappa, K., John, V., Parepally, H., Gershon, S., Schlicht, P., & Kupfer, D. J.
Venue
Bipolar Disorders
Publisher
Wiley
Published
2004-06-28
Volume
6
Issue
4
Pages
314-318
ISSN
  • 1398-5647 (ISSN-L)
  • 1399-5618
OpenAlex
W2044738289
Cited by
134
References
4
FWCI
7.91
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The prevalence of the metabolic syndrome in patients with schizoaffective disorder – bipolar subtype. https://app.cochat.ai/papers/10.1111/j.1399-5618.2004.00126.x
The paper
Basu, R., Brar, J. S., Roy Chengappa, K., John, V., Parepally, H., Gershon, S., Schlicht, P., & Kupfer, D. J. (2004). The prevalence of the metabolic syndrome in patients with schizoaffective disorder – bipolar subtype. Bipolar Disorders. https://doi.org/10.1111/j.1399-5618.2004.00126.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.